Umbilical cord blood, a source of potentially life-saving stem cells, is increasingly becoming a consideration for expectant parents, with options ranging from donation to private storage. The collection process, described as quick and painless for both mother and baby, occurs immediately following delivery.
Cord blood contains stem cells that can develop into various blood and immune cells, offering treatment possibilities for a range of diseases including leukemia, sickle cell anemia, and certain genetic disorders. Research is also underway to explore the potential of these stem cells in treating conditions like autism, brain injuries, and diabetes.
Parents have two primary paths when it comes to cord blood: donation to a public bank or private storage. Public donation makes the cord blood available for anyone in require, while private banking reserves it for potential use by the family. According to Frances Verter, Ph.D., founder of the Parent’s Guide to Cord Blood Foundation, only about 5% of U.S. Parents choose to bank cord blood, with approximately 90% opting for private storage and 10% donating to public banks.
The decision to donate or bank privately involves weighing the costs and benefits. Public donation is free, while private storage incurs fees. Private banks offer the potential for personalized access to the stem cells, but the likelihood of needing them for a family member remains a key consideration.
The process of collecting cord blood does not interfere with the delivery of the baby. It is performed after the baby is born and the umbilical cord is clamped.
A BabyCenter community forum indicates parents are actively comparing different cord blood banks, such as Cryocell, CBR, Viacord, and Americord, often seeking discounts or evaluating specific services like viability testing and genetic testing of the stem cells.
